How Is IBS Diagnosed?

Irritable Bowel Syndrome (IBS) affects up to 15% of the global population, yet its diagnosis often feels elusive and frustrating. Statistics say that it often takes up to 6 years and visits with three or more healthcare providers to receive a diagnosis. Don’t become one of these statistics. Advocate for yourself. This article explains what you should be asking for from your medical doctor. 

The Summary: How is IBS Diagnosed? A healthcare provider reviews your symptoms, medical history, bowel patterns, and any red flag symptoms (see below), while also considering the many conditions that can mimic IBS. Appropriate testing is often necessary to rule out diseases such as celiac disease, inflammatory bowel disease (IBD), colorectal cancer, infection, endometriosis, and other digestive or gynecologic disorders when indicated. Healthcare providers may then apply the Rome V clinical criteria to help make a positive diagnosis of IBS based on symptom patterns and current scientific understanding of Disorders of Gut-Brain Interaction (DGBIs).

There are many medical issues that mimic IBS, and some of them are deadly. You have to go through a correct diagnosis protocol in order to know how to address your symptoms.

Never Self-Diagnose

We wish we didn’t have to say this, but DO NOT SELF-DIAGNOSE. We see it happen all the time and it can lead to even more dire problems. There are many medical issues that mimic IBS, and some of them are deadly. You have to go through a correct diagnosis protocol in order to know how to address your symptoms. It might be IBS; it might not. About 36% of you will have IBS along with additional digestive issues, and treatment is going to be unique to your medical presentation (we all have unique gastrointestinal tracts). 

Still Not Convinced? Have Any Red Flag Symptoms?

As mentioned, there are medical diseases and syndromes that can mimic IBS. If you have any of these red flag symptoms, please do not wait. Get a medical diagnosis now.

• Unintentional weight loss
• Rectal bleeding or blood in the stool
• Anemia (especially iron-deficiency anemia)
• Fever
• Nocturnal symptoms (diarrhea waking you from sleep)
• Family history of colorectal cancer, IBD, or celiac disease
• Onset after age 50 (in someone previously symptom-free)
• Persistent severe pain that’s not relieved by passing gas or a bowel movement

IBS Diagnosis Has Evolved Under Rome V

IBS diagnosis has changed significantly in recent years. Historically, IBS was often viewed primarily as a diagnosis of exclusion, meaning healthcare providers first had to rule out every possible digestive disease before considering IBS. While appropriate testing remains extremely important—especially because many serious conditions can mimic IBS—modern Rome V guidelines also support making a positive diagnosis based on symptom patterns, medical history, physical examination, and current understanding of Disorders of Gut-Brain Interaction (DGBIs).

The goal is not to reduce testing when it is medically necessary. Rather, Rome V encourages clinicians to recognize IBS earlier and more confidently once appropriate evaluation has been performed and alarm symptoms or other diseases have been reasonably excluded.

Ruling Out Other Conditions

If your doctor wants to run tests, they might include:

• Complete Blood Count (CBC): Checks for anemia or infection
• C-reactive Protein (CRP) or Fecal Calprotectin: To assess inflammation, especially to screen for Inflammatory Bowel Disease (IBD) like Crohn’s disease or ulcerative colitis
• Celiac Disease Blood Panel: Screens for autoimmune reaction to gluten
• Stool Studies: To rule out parasites, infections, or malabsorption
• Colonoscopy or Sigmoidoscopy: Especially for adults over 45 or those with red flag symptoms

Applying the Rome V Criteria

The Rome Foundation develops internationally recognized guidelines used to diagnose Disorders of Gut-Brain Interaction (DGBIs), including IBS. The newest version, Rome V, released in 2026, distinguishes between research criteria and clinical criteria.

Research criteria are intentionally stricter to create uniform study populations, while clinical criteria allow healthcare providers to better address how IBS presents in real-world patients.

This change recognizes that real patients do not always fit neatly into research definitions. Clinical criteria give healthcare providers greater flexibility to diagnose IBS when symptoms and medical history strongly support the diagnosis.

DGBIs can involve gut hypersensitivity, motility issues, and microbial imbalances. This modern understanding has helped reduce the stigma of IBS as “all in your head” and supports a more holistic treatment approach.

One of the most significant changes in Rome V is the reintroduction of abdominal discomfort as a qualifying symptom. Under Rome IV, abdominal pain was required for diagnosis. However, many patients with IBS experience bloating, pressure, fullness, cramping, or generalized discomfort rather than what they would specifically describe as pain. Rome V recognizes that IBS symptoms can present differently from person to person.

Rome V also lowers the symptom threshold to better reflect how IBS appears in real-world clinical practice. These updates are expected to help more patients receive an accurate diagnosis and appropriate treatment sooner, particularly those whose symptoms may previously have fallen into a gray area under older criteria.

IBS Is Increasingly Diagnosed Positively

For many years, IBS was often described as a diagnosis of exclusion, meaning doctors first had to rule out every possible digestive disease. While it remains important to identify conditions such as celiac disease, inflammatory bowel disease, colorectal cancer, infection, or endometriosis when indicated, modern IBS diagnosis increasingly focuses on making a positive diagnosis based on symptoms, medical history, physical examination, and appropriate testing.

This approach helps reduce unnecessary delays in diagnosis and allows patients to begin evidence-based treatment sooner.

How the Low FODMAP Diet Fits Into Rome V

One of the most important shifts reflected in Rome V is the recognition that IBS treatment often requires a multidisciplinary approach rather than medication alone. Rome V formally acknowledges dietary therapy, including the low FODMAP diet, as part of evidence-based management for Disorders of Gut-Brain Interaction (DGBIs).

This does not mean the low FODMAP diet diagnoses IBS by itself. Rather, after appropriate medical evaluation and any necessary testing have ruled out other conditions, a patient’s response to dietary intervention may help clarify the overall clinical picture. Many people with IBS experience significant improvement in bloating, abdominal pain, diarrhea, gas, and other symptoms when following a properly conducted low FODMAP diet.

Rome V also reflects modern understanding that IBS involves complex interactions among the gut microbiome, nervous system, immune system, gastrointestinal motility, and communication between the gut and brain. Because food can influence many of these processes, diet has become an increasingly important part of comprehensive IBS management.

Importantly, the Elimination Phase of the low FODMAP diet is not intended to be followed long term. Rome V’s multidisciplinary model reinforces the importance of working with a dietitian trained in digestive health and DGBIs to personalize treatment, protect nutritional adequacy, and avoid unnecessary long-term restriction.

Studies show that up to 75% of people with IBS experience relief on a low FODMAP diet, although it must be implemented under the supervision of a trained dietitian, for this high percentage result.

Other Helpful Tests

In select cases, additional tests may be warranted:

• Hydrogen and Methane Breath Tests: To screen for SIBO (small intestinal bacterial overgrowth) or sugar malabsorption, such as lactose or fructose intolerance. SIBO is controversial and difficult to diagnose accurately, but may coexist with IBS.
• Anorectal Manometry: Used for chronic constipation to assess muscle coordination in the pelvic floor
• Gynecological Evaluation: For women with possible endometriosis, especially when symptoms worsen with menstrual cycles

Though there is no universally applicable diagnostic tool for all IBS forms, there is a relatively new, commercially available antibody blood test called IBS-Smart. This test measures biomarkers associated with IBS-D and IBS-M, which may be elevated following infectious gastroenteritis and presents a potential diagnostic option for post-infectious IBS-D and IBS-M. As always, consult with your trusted health professional to learn more if they believe this may be a useful tool in your diagnosis Please read our previously published article that discusses this test for more information, and discuss the advantages and limitations with your medical team.

Final Thoughts

Proper evaluation begins with a thorough medical history, review of symptoms, identification of any alarm features, and appropriate testing when indicated. Healthcare providers can then apply the Rome V clinical criteria to make a positive diagnosis of IBS. Treatment often includes a multidisciplinary approach involving a gastroenterologist, dietitian, behavioral therapies, and medical management tailored to the individual.

If you suspect you have IBS, speak with a gastroenterologist and consider working with a Monash-trained dietitian and building a multidisciplinary team. Don’t self-diagnose—and don’t give up. Relief is possible, and the right diagnosis and treatment approach make all the difference.

---

Additional Sources and References:

From FODMAP Everyday®:

• The Role Of The Dietitian vs. The Gastroenterologist
• What Is IBS?
• Deadly Diseases That Mimic IBS
• Understanding the Relationship Between Endometriosis & IBS
• Understanding the Overlap Between IBS & Anxiety
• Have IBS? Top Reasons To Work With A Dietitian
• How To Choose A Dietitian
• Dietitians & Nutritionists: What’s The Difference?
• Patient Dos And Don’ts For A Great Telehealth Appointment 

Other:

• Rome V Diagnostic Criteria
• IBS Overview – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Celiac Disease Diagnosis – NIDDK
• ACG IBS Clinical Guidelines (2021) – American Journal of Gastroenterology
• IBD and IBS Symptom Comparison